Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Rapport Therapeutics (NASDAQ:RAPP) through any online brokerage.
Other companies in Rapport Therapeutics’s space includes: Atai Beckley NV (NASDAQ:ATAI), Xeris Biopharma Holdings Inc (NASDAQ:XERS), Phibro Animal Health Corp (NASDAQ:PAHC), ANI Pharmaceuticals Inc (NASDAQ:ANIP) and Perrigo Co PLC (NYSE:PRGO).
Rapport Therapeutics has a consensus price target of $43.88.
The stock price for Rapport Therapeutics (NASDAQ: RAPP) is $30.245 last updated December 15, 2025 at 11:17 AM EST.
There are no upcoming dividends for Rapport Therapeutics.
Rapport Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Rapport Therapeutics.
Rapport Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.